UK OTC Sales Have Off Year In 2004 After Period Of Growth
This article was originally published in The Tan Sheet
UK sales of OTC cough/cold products declined 4.2% in 2004 to $698 mil., according to IRI data released by the Proprietary Association of Great Britain May 11
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC